Psychometric Validation and Scale Derivation of the ICIQ‐Underactive Bladder Patient Reported Outcome Measure
The two scored domains and associated bother for the ICIQ-UAB have been shown to be reliable, valid and sensitive to the severity of the condition. The instrument can be recommended to researchers and clinicians for the comprehensive assessment of symptoms and their impact on HRQoL on patients with suspected UAB.
Authors
- Paul Abrams (ORCID: https://orcid.org/0000-0003-2776-2200)
- Zalmaï Hakimi (ORCID: https://orcid.org/0000-0001-5835-8599)
- Nikki Cotterill (ORCID: https://orcid.org/0000-0001-6921-2712)
- Carrie Atzinger (ORCID: https://orcid.org/0000-0001-9675-1930)
- Elizabeth D. Bacci
- J. W. Olivier van Till (ORCID: https://orcid.org/0000-0002-2395-9332)
- Scott Doyle
- Alan Uren (ORCID: https://orcid.org/0000-0001-7486-2322)
- Karin S. Coyne (ORCID: https://orcid.org/0000-0002-5773-131X)
Institutions
- University of the West of England (GB)
- Southmead Hospital (GB)
- Astellas Pharma (Netherlands) (NL)
- Gramercy Research Group (United States) (US)
Publication Details
- Journal
- Neurourology and Urodynamics
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1002/nau.70065
- Primary Topic
- Pelvic floor disorders treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Astellas Pharma
- Astellas Pharma Europe